Home
Welcome to the ACT Consortium
The ACT Consortium is a global research partnership formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.
Although there is considerable evidence about the efficacy of artemisinin-based combination therapy (ACTs), there is little evidence on how best to deploy this WHO-recommended treatment.
Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality.
The ACT Consortium is funded by the Bill and Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States. It is coordinated through the London School of Hygiene and Tropical Medicine.
News
July 2010
Listen to Dr. Shunmay Yeung, Clinical Senior Lecturer in Health Economics and Policy at LSHTM, and member of the ACT Consortium's core science team, speak to Sarah Maxwell of Audio Medica on techniques being developed to help cope with the threat of increasing ACT drug resistance.